Your browser doesn't support javascript.
loading
A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy.
Berdel, Andrew F; Koch, Raphael; Gerss, Joachim; Hentrich, Marcus; Peceny, Rudolf; Bartscht, Tobias; Steffen, Björn; Bischoff, Marina; Spiekermann, Karsten; Angenendt, Linus; Mikesch, Jan-Henrik; Kewitz, Tobias; Butterfass-Bahloul, Trude; Serve, Hubert; Lenz, Georg; Berdel, Wolfgang E; Krug, Utz; Schliemann, Christoph.
Affiliation
  • Berdel AF; Department of Medicine A, University Hospital Münster, Albert-Schweitzer-Campus 1, 48149, Münster, Germany.
  • Koch R; Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany.
  • Gerss J; Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany.
  • Hentrich M; Department of Hematology and Oncology, Red Cross Hospital, Munich, Germany.
  • Peceny R; Department of Oncology, Hematology and Stem Cell Transplantation, Klinikum Osnabrück, Osnabrück, Germany.
  • Bartscht T; Department of Medicine I, University Hospital Lübeck, Lübeck, Germany.
  • Steffen B; Department of Medicine II, University Hospital Frankfurt, Frankfurt, Germany.
  • Bischoff M; Department of Hematology and Oncology, Klinikum Idar-Oberstein, Idar-Oberstein, Germany.
  • Spiekermann K; Department of Medicine III, University Hospital Munich, Ludwig-Maximilians-University, Munich, Germany.
  • Angenendt L; Department of Medicine A, University Hospital Münster, Albert-Schweitzer-Campus 1, 48149, Münster, Germany.
  • Mikesch JH; Department of Medicine A, University Hospital Münster, Albert-Schweitzer-Campus 1, 48149, Münster, Germany.
  • Kewitz T; Centre for Clinical Trials, University of Münster, Münster, Germany.
  • Butterfass-Bahloul T; Centre for Clinical Trials, University of Münster, Münster, Germany.
  • Serve H; Department of Medicine II, University Hospital Frankfurt, Frankfurt, Germany.
  • Lenz G; Department of Medicine A, University Hospital Münster, Albert-Schweitzer-Campus 1, 48149, Münster, Germany.
  • Berdel WE; Department of Medicine A, University Hospital Münster, Albert-Schweitzer-Campus 1, 48149, Münster, Germany.
  • Krug U; Department of Medicine A, University Hospital Münster, Albert-Schweitzer-Campus 1, 48149, Münster, Germany.
  • Schliemann C; Department of Medicine, III, Hospital Leverkusen, Leverkusen, Germany.
Ann Hematol ; 102(1): 63-72, 2023 Jan.
Article in En | MEDLINE | ID: mdl-36399194
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Cytarabine Type of study: Clinical_trials Limits: Aged / Aged80 / Humans Language: En Journal: Ann Hematol Journal subject: HEMATOLOGIA Year: 2023 Type: Article Affiliation country: Germany
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Cytarabine Type of study: Clinical_trials Limits: Aged / Aged80 / Humans Language: En Journal: Ann Hematol Journal subject: HEMATOLOGIA Year: 2023 Type: Article Affiliation country: Germany